CompoAtlas

CURCUMA POIVRE

Food supplement declared in France, decision dated 16 July 2026

CURCUMA POIVRE is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.

Brand
not provided
Food business operator placing the product on the market
SENTIER NATURE
Status
Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form
Gélule
Daily dose
2 gélules
Directions for use
1 à 2 gélules par jour avec un verre d'eau
Intended populations
Hommes et femmes de 18 ans et plus
Not recommended for (according to the manufacturer)
Adolescents (moins de 18 ans), Femmes allaitantes, Femmes enceintes, Sous anticoagulants
Objectives stated by the manufacturer (these are not authorised claims)
Antioxydant

Declaration 370974, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

None of the rules we check applies to the declared ingredients.

Declared composition

Plants

PlantPartPreparationPer day
Curcuma longa L.RhizomePoudre (de plantes séchées ou broyées)400 mg
Curcuma longa L.RhizomeAutre extrait fluide130 mg
Piper nigrum L.BaieAutre extrait sec10 mg

Additives

E1204

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Has the product changed? Photograph the packaging.

Label warnings

Déconseillé aux personnes souffrant de pathologies de voies biliaires, sous anticancéreux et immunosuppresseurs.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Other declarations with the same name

This name is used by more than 10 declarations from different companies, so it does not identify one product. See every declaration with this name.

Enter to analyse, Shift+Enter for a new line